EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes

Mohammed Ayyad, Walaa Abu Alya, Anas Mufeed Barabrah, Sara Mohammed Darawish, Yazan AlHabil, Majdeddin MohammedAli, Mustafa Zafer Nabilsi, Diya Asad, Laith A Ayasa, Daniel Matassa

Clinical Immunology · 2025

DOI: 10.1016/j.clim.2025.110512 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Immunology, 2025. Verfasst von Mohammed Ayyad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: dr.mohammad.ayyad@gmail.com. Hauptthemen laut MEDLINE: Anemia, Hemolytic, Autoimmune, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: COVID-19 has been linked to autoimmune hemolytic anemia (AIHA), a rare but serious condition causing red blood cell destruction. This systematic review examines the clinical characteristics, management, and outcomes of AIHA in COVID-19 patients. METHODS: A systematic search of PubMed, CINAHL, and Scopus identified 85 studies encompassing 105 patients. Data on demographics, clinical features, and treatment outcomes were extracted. RESULTS: Of 1402 articles, 85 met inclusion criteria. Most patients were male (54.3 %) with a mean age of 50.6 years, predominantly from Asia (83.5 %). Cold agglutinin AIHA was most common (48.2 %). Presenting symptoms included fatigue, dyspnea, and fever. Steroids were the most effective treatment, used in 95 % of recovered cases. Mortality was 14.3 %, with 26.7 % of deaths directly related to AIHA. CONCLUSIONS: COVID-19 is associated with AIHA, often presenting with non-specific symptoms. Early recognition and prompt steroid therapy are critical for improving outcomes. Further research is needed to guide management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Hemolytic, AutoimmuneCOVID-19HumansSARS-CoV-2MaleFemaleMiddle AgedTreatment OutcomeSteroidsAdult

Stichwörter der Autor:innen

AIHA COVID-induced hemolysisAutoimmune hemolytic anemiaCOVID-19Immune-mediated hemolysisSARS-CoV-2

Substanzen

Steroids

Autor:innen und Institutionen

  • Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: dr.mohammad.ayyad@gmail.com.
  • Department of Medicine, Cleveland Clinic Fairview Hospital, Cleveland, OH, USA.
  • Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
  • Department of Medicine, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus 00970, Palestine.
  • Department of General Surgery, Brooklyn Hospital Center, Brooklyn, NY, USA.
  • Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

Zitieren

APA

Ayyad, M., Abu Alya, W., Barabrah, A. M., Darawish, S. M., AlHabil, Y., MohammedAli, M., Nabilsi, M. Z., Asad, D., Ayasa, L. A., & Matassa, D. (2025). Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110512

Vancouver

Ayyad M, Abu Alya W, Barabrah AM, Darawish SM, AlHabil Y, MohammedAli M, et al. Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110512

BibTeX
@article{Ayyad2025,
  author = {Ayyad, Mohammed and Abu Alya, Walaa and Barabrah, Anas Mufeed and Darawish, Sara Mohammed and AlHabil, Yazan and MohammedAli, Majdeddin and Nabilsi, Mustafa Zafer and Asad, Diya and Ayasa, Laith A and Matassa, Daniel},
  title = {Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes},
  journal = {Clinical Immunology},
  year = {2025},
  doi = {10.1016/j.clim.2025.110512}
}
Kostenlos starten →